Snapshots Austria Pharmaceuticals

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Flughafen Wien AG (FLU) - Company Capsule

Flughafen Wien AG (FLU) - Company Capsule

  • $ 75
  • Company report
  • by World Market Intelligence Ltd
  • September 2014
  • 21 pages

Synopsis World Market Intelligence's "Flughafen Wien AG (FLU) - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, financial ratios, key competitors, financial analysis, recent ...

Industries: Pathology | Countries: Austria, World

botiss dental GmbH - Product Pipeline Analysis, 2014 Update

botiss dental GmbH - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • September 2014
  • 23 pages

Summary botiss dental GmbH (botiss dental) is a dental product provider. The company provides biologic regenerative solutions for implantology, oral surgery, CMF and periodontology. It offers products such as bone regeneration and tissue regeneration. botiss dental's bone regenerations include bovine, ...

Industries: Drug Discovery and Development | Countries: United Kingdom, Germany, Austria

Austria Pharmaceuticals and Healthcare Report Q4 2014

Austria Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • September 2014
  • 68 pages

Includes 3 FREE quarterly updates BMI View: BMI has upwardly revised its pharmaceutical and healthcare forecasts for Austria, reflecting the country's improving economic prospects and attractiveness of these sectors in particular. The United States Commerce department has listed Austria as one of the ...

Industries: Drug and Medication | Countries: Austria

Aesica Pharmaceuticals Limited SWOT Analysis, Strategy, Revenues and Profits

Aesica Pharmaceuticals Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • September 2014
  • 31 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pharmaceutical | Countries: Italy, Germany, China, Switzerland, Austria, Europe, United States

Actinic (Solar) Keratosis - Pipeline Review, H2 2014

Actinic (Solar) Keratosis - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • August 2014
  • 92 pages

Actinic (Solar) Keratosis - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Actinic (Solar) Keratosis - Pipeline Review, H2 2014', provides an overview of the Actinic (Solar) Keratosis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development fo ...

Industries: Pathology | Countries: World, Austria

Sandoz International GmbH SWOT Analysis, Strategy, Revenues and Profits

Sandoz International GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Generic Drug | Countries: Germany, India, Argentina, Brazil, Canada, Slovenia, Poland, Austria

Nuvilex, Inc. (NVLX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nuvilex, Inc. (NVLX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • July 2014
  • 21 pages

Summary Nuvilex, Inc. (Nuvilex) is a biotechnology company. The company operates with live-cell encapsulation technology to enclose living cells in protective cocoons about the size of the head of a pin. Its capsule can enclose 10,000 cells and depending upon the size of the cells encapsulated. Nuvilex's ...

Industries: Pathology | Countries: United States, Austria

Biocrates Life Sciences AG - Product Pipeline Analysis, 2014 Update

Biocrates Life Sciences AG - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • July 2014
  • 32 pages

Summary Biocrates Life Sciences AG (Biocrates) is a biotechnology company. The company develops metabolomic products and vitro diagnostics (IVDs) for early disease detection. Its metabolomic solutions set a new level of standardized data processing, exchange, and storage, which can readily meet the rigorous ...

Industries: Pathology | Countries: Austria

Global Vitamin and Provitamin Market to 2018 - Market Size, Growth, and Forecasts in Nearly 70 Countries

Global Vitamin and Provitamin Market to 2018 - Market Size, Growth, and Forecasts in Nearly 70 Countries

  • $ 2 488
  • Industry report
  • by MarketSizeInfo
  • July 2014

This is a comprehensive publication that enables readers the critical perspectives to be able to evaluate the world market for vitamins and provitamins. The publication provides the market size, growth and forecasts at the global level as well as for the following countries: Argentina, Armenia, Australia, ...

Industries: Vitamin and Supplement | Countries: World, Europe, Asia, South America, Czech Republic, South Korea, Philippines, Australia, Argentina, United States, United Kingdom, Netherlands, Macedonia, Lithuania, Sri Lanka, Singapore, Kazakhstan, Indonesia, Azerbaijan, South Africa, Africa, Uruguay, Ecuador, Chile, Colombia, Bolivia, Panama, Mexico, Canada, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Moldova, Republic Of, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Bulgaria, Belgium, Austria, Vietnam, Thailand, Pakistan, Malaysia, Lebanon, Jordan, Japan, India, China, Georgia, Armenia, Senegal, Nigeria, Morocco, Ghana, Ethiopia, Egypt, North America, Peru, Oman

MarketVIEW - Meningitis ACWY vaccines

MarketVIEW - Meningitis ACWY vaccines

  • $ 4 495
  • Industry report
  • by VacZine Analytics Group Of Assay Advantage Ltd
  • July 2014
  • 85 pages

Gram-negative Neisseria meningitidis (N.men) is an important contributor to bacterial meningitis. Of the estimated 1.2 million cases which occur each year (WHO Figures), N.men is thought to be responsible for around 40% of the total where 5 main serogroups ACWY and B are responsible for the majority ...

Industries: Drug and Medication | Countries: World, United States, Europe, Chile, South America, Saudi Arabia, Africa, United Kingdom, South Korea, Brazil, France, Asia, Argentina, Indonesia, Colombia, Mexico, Spain, Italy, Greece, Germany, Austria, Pakistan, Malaysia, North America

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.